Liposomes modify the subcellular distribution of sclareol uptake by HCT-116 cancer cell lines

Biomedicine and Pharmacotherapy

Volumn 61, Issue 2-3, 2007, Pages 120-124

  Paradissis, Agnès ^a,b   Hatziantoniou, Sophia ^b   Georgopoulos, Aristidis ^b   Psarra, Anna Maria G ^c   Dimas, Konstantinos ^c   Demetzos, Costas ^b  

^a PSL RESEARCH UNIVERSITY   (France)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c Foundation for Biomedical Research   (Greece)

Author keywords

Liposome; Sclareol; Subcellular fractionation; Uptake

Indexed keywords

DITERPENE; LIPOSOME; SCLAEROL; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN HCT116; CELLULAR DISTRIBUTION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CYTOSOL; DELAYED-ACTION PREPARATIONS; DITERPENES; HCT116 CELLS; HUMANS; LIPOSOMES; SUBCELLULAR FRACTIONS; TIME FACTORS;

EID: 34147207826     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.10.006     Document Type: Article

References (18)

1. Demetzos C., and Dimas K. In: Atta-ur-Rahman (Ed). Studies in natural product chemistry. Labdane type diterpenes: chemistry and biological activity vol. 25 (2001), Elsevier 235-292
2. Demetzos C., Stahl B., Anastasaki T., Gazouli M., Tzouvelekis L., and Rallis M. Chemical analysis and antimicrobial activity of the resin ladano of its essential oil and of the isolated compounds. Planta Med 65 (1999) 76-78
3. Demetzos C. A phytochemical study on Cistus incanus subsp. creticus (I). Isolation, structure elucidation and synthesis of a new flavonoid glycoside from Kalanchoe prolifera. R. Hamel (II). Ph. D. Thesis, Athens, Greece; 1990.
4. Dimas K., Papadaki M., Tsimplouli C., Hatziantoniou S., Alevizopoulos K., Pantazis P., et al. Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs. Biomed Pharmacother 60 3 (2006) 127-133
5. Allen T.M., and Stuart D.D. Liposomes pharmacokinetics. In: Janoff S. (Ed). Liposomes rational design (1999), Marcel Dekker, Inc., N. York, Basel 63
6. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51 (1999) 691-743
7. Hatziantoniou S., Dimas K., Georgopoulos A., Sotiriadou N., and Demetzos C. Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol Res 53 (2006) 80-87
8. Celis J. Tissue culture and associate techniques. Cell biology: a laboratory handbook (1994), Academy Press, Inc 10
9. Wiley J., and Sons. Basic techniques for mammalian cell tissue culture. Current protocols in cell biology (1998), John Wiley&Sons, New York 1.1.1-1.1.8
10. Bligh E.G., and Dyer W.I. A rapid method of total lipid extraction and purification. Canad J Biochem Physiol 37 (1959) 911-917
11. Psarra A.M.G., Solakidi S., Trougakos I.P., Margaritis L.H., Spyrou G., and Sekeris C.E. Glucocorticoid receptor isoforms in human hepatocarcinoma HepG2 and SaOS-2 osteosarcoma cells: presence of glucocorticoid receptor alpha in mitochondria and of glucocorticoid receptor beta in nucleoli. Int J Biochem Cell Biol 37 12 (2005) 2544-2558
12. Liu F.T., Kelsey S.M., Newland A.C., and Jia L. Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells. Br J Haematol 117 2 (2002) 333-342
13. Kshirsagar N.A., Pandya S.K., Kirodian B.G., and Sanath S. Liposomal drug delivery system from laboratory to clinic. J Postgrad Med 51 (2005) 5-15
14. Zamboni W.C. Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin Cancer Res 11 (2005) 8230-8234
15. Chen Y., Dalwadi G., and Benson H.A. Drug delivery across the blood-brain barrier. Curr Drug Deliv 1 (2004) 361-376
16. Bartsch M., Weeke-Klimp A.H., Meijer D.K., Scherphof G.L., and Kamps J.A. Cell-specific targeting of lipid-based carriers for ODN and DNA. J Liposome Res 15 (2005) 59-92
17. Batist G., Ramakrishnan G., Rao C.S., Chandrasekharan A., Gutheil J., Guthrie T., et al. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J Clin Oncol 19 (2001) 1444-1454
18. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55 (1995) 3752-3756